ANALYST REITERATES BUY ON SOME DRUG STOCKS New York March Merrill Lynch and Co analyst Richard Vietor said he reiterated a buy recommendation on several drug stocks today The stocks were Bristol Myers Co BMY which rose to Schering Plough Corp SGP to and Syntex Corp SYN to Vietor described these stocks as a middle group of performers Vietor said the prices of these stocks look pretty cheap relative to the leading performers in the drug group such as Upjohn Co UPJ Merck and Co Inc MRK and Squibb Corp SQB Vietor said he also mentioned Pfizer Inc PFE up two to and Warner Lambert Co WLA up to as being in the middle group But he did not recommend those stocks which he rates as neutral Reuter